Whole-body hyperthermia combined with ifosfamide and carboplatin causes hypotension and nephrotoxicity

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 10, 1998, Pages 549-554

  Brauer, Lance P ^a   Prieshof, Bernd ^a   Wiedemann, Günter J ^a   Weiss, Christoph ^a   Kriz, Wilhelm ^b   Schramm, Uda ^a   Robins, H Ian ^c   Pagel, Horst ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Department of Medicine K4/666 ^*  (United States)

Author keywords

Carboplatin; Ifosfamide; Nephrotoxicity; Whole body hyperthermia

Indexed keywords

CARBOPLATIN; IFOSFAMIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CANCER COMBINATION CHEMOTHERAPY; CATECHOLAMINE RELEASE; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERTHERMIC THERAPY; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY PERFUSION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; HYPERTHERMIA, INDUCED; HYPOTENSION; IFOSFAMIDE; KIDNEY DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031791036     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050213     Document Type: Article

References (14)

1. Gutsche S, Kurowski V, Wagner T, Weiss C, Wiedemann GJ (1995) Dose-temperature dependence of the therapeutic efficacy of oxazaphosphorine compounds. J Clin Pharm Pract 1:14
2. Ohno S, Siddik ZH, Baba H, Stephens LC, Strebel FR, Wondergem J, Khokhar AR, Bull JM (1991) Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Cancer Res 51:2994-3000
3. Pagel H, Jelkmann W, Weiss C (1991) Isolated serum-free perfused rat kidneys release immunoreactive erythropoietin in response to hypoxia. Endocrinology 128:2633-2638
4. Robins HI, Cohen JD, Schmitt CL, Tutsch K, Feierabend C, Arzoomanian R, Alberti D, d'Oleire F, Longo W, Heiss C (1993) Phase I trial of carboplatin and 41.8°C whole body hyperthermia in cancer patients. J Clin Oncol 11:1787-1794
5. Robins HI, Woods JP, Schmitt CL, Cohen JD. (1994) A new technological approach to radiant heat whole body hyperthermia. Cancer Lett 79:137-145
6. Robins HI, Rushing D, Kutz M, Tutsch KD, Tiggelaar CL, Paul D, Spriggs D, Kraemer C, Gillis W, Feierabend C, Arzoomanian RZ, Longo W, Alberti D, d'Oleire F, Qu RP, Wilding G, Stewart JA (1997) Phase I clinical trial of melphalan and 41.8°C whole body hyperthermia in cancer patients. J Clin Oncol 15:158-164
7. Weiss C, Passow H, Rohstein A (1959) Autoregulation of flow in isolated rat kidney in the absence of red cells. Am J Physiol 196:1115-1118
8. Wiedemann GJ, Roszinski S, Biersack A, Weiss C, Wagner T (1992) Local hyperthermia enhances cyclophosphamide, ifosfamide, and cis-diamminedichloroplatimun cytotoxicity on human derived breast carcinoma and sarcoma xenografts in nude mice. J Cancer Res Clin Oncol 118:129-135
9. Wiedemann GJ, Siemens A, Mentzel M, Biersack A, Wossmann W, Knocks D, Weiss C, Wagner T (1993) Effects of temperature on the therapeutic efficacy and pharmacokinetic of ifosfamide. Cancer Res 53:4268-4272
10. Wiedemann GJ, d'Oleire F, Eleftheriadis S, Bucsky P, Knop E, Feddersen S, Klouche M, Geisler J, Mentzel M, Schmucker P, Weiss C, Wagner T (1994) Ifosfamide and carboplatin combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Res 54:5346-5350
11. Wiedemann GJ, Katschinski DM, Mentzel M, Wagner T, Touhidi R, d'Oleire F, Robins HI (1996a) Ifosfamide, carboplatin and etoposide (ICE) combined with Aquatherm-induced 41.8°C whole-body hyperthermia (WBH) for refractory sarcoma. J Clin Oncol 14:17-51
12. Wiedemann GJ, Robins HI, Gutsche S, Katschinski DM, Mentzel M, Deeken M, Eleftheriadis S, Crahe R, Weiss C, Storer B, Wagner T (1996) Ifoslamide, carboplatin, and etoposide (ICE) combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma: a phase II study. Eur J Cancer [A] 32:888-892
13. Wiedemann GJ, Robins HI, Katschinski DM, Mentzel M, d'Oleire F, Wagner T (1997) Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status. Anticancer Res 17:2899-2902
14. Zamlauski-Tucker MJ, Morris ME, Springate JE (1994) Ifosfamide metabolite chloroacetaldehyde causes Fanconi syndrome in the perfused rat kidney. Toxicol Appl Pharmacol. 129:170-175